Activity of Meropenem-Vaborbactam against Carbapenem-Resistant Enterobacteriaceae in a Murine Model of Pyelonephritis
Keyword(s):
ABSTRACT The recently approved combination of meropenem and vaborbactam (Vabomere) is highly active against Gram-negative pathogens, especially Klebsiella pneumoniae carbapenemase (KPC)-producing, carbapenem-resistant Enterobacteriaceae. We evaluated the efficacy of meropenem-vaborbactam against three clinically relevant isolates in a murine pyelonephritis model. The data indicate that the combination of meropenem and vaborbactam significantly increased bacterial killing compared to that with the untreated controls. These data suggest that this combination may have utility in the treatment of complicated urinary tract infections due to KPC-producing, carbapenem-resistant Enterobacteriaceae.
2017 ◽
Vol 13
(5)
◽
pp. 495.e1-495.e6
◽
2014 ◽
Vol 59
(1)
◽
pp. 553-557
◽
2019 ◽
Vol 6
(Supplement_2)
◽
pp. S524-S524
2019 ◽
Vol 149
(2)
◽
pp. 185
◽
Keyword(s):